Technetium Tc 99m tilmanocept fails to detect sentinel lymph nodes in endometrial cancer

• Hoofdauteurs: Ravali A. Reddy (Auteur), Ashley S. Moon (Auteur), Stephanie Chow (Auteur), Lucas Heilbroner (Auteur), Brooke Howitt (Auteur), Elisabeth Diver (Auteur), Oliver Dorigo (Auteur), Babak Litkouhi (Auteur), Malte Renz (Auteur), Amer Karam (Auteur)
• Formaat: Boek
• Gepubliceerd in: Elsevier, 2022-10-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Technetium Tc 99m tilmanocept is a synthetic radiotracer specifically designed for sentinel lymph node (SLN) mapping that has been FDA-approved in breast cancer, melanoma, and head and neck cancer. No published studies exist for the use of this radiotracer in endometrial cancer. Objectiv...